|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ROBERT L. EHRLICH, JR., Governor
|
|
H.B. 1287
|
|
|
|
|
|
|
|
|
|
|
|
|
PHARMACEUTICAL CARE AND ON CURBING PRESCRIPTION DRUG DIVERSION IN THE
STATE, INCLUDING ANY RECOMMENDATIONS RELATED TO MODIFICATION OR
CONTINUATION OF THE PROGRAM; AND
(4) PROVIDE ONGOING ADVICE AND CONSULTATION ON THE
IMPLEMENTATION AND OPERATION OF THE PROGRAM, INCLUDING
RECOMMENDATIONS REGARDING:
(I) CHANGES IN THE PROGRAM TO REFLECT ADVANCES IN
TECHNOLOGY AND BEST PRACTICES IN THE FIELD OF ELECTRONIC HEALTH
RECORDS AND ELECTRONIC PRESCRIPTION MONITORING; AND
(II) EMERGING DRUGS OF CONCERN THAT SHOULD BE IDENTIFIED
AS MONITORED PRESCRIPTION DRUGS; AND
(III) (II) THE DESIGN AND IMPLEMENTATION OF AN ONGOING
EVALUATION COMPONENT OF THE PROGRAM.
21-2A-04.
(A) THE SECRETARY SHALL APPOINT A MULTIDISCIPLINARY CONSULTATION
TEAM WITHIN THE PROGRAM.
(B) THE MULTIDISCIPLINARY CONSULTATION TEAM SHALL REFLECT THE
DIVERSITY AND BALANCE OF PERSPECTIVES REPRESENTED ON THE BOARD.
(B) (C) THE MULTIDISCIPLINARY CONSULTATION TEAM SHALL CONSIST OF:
(1) PROGRAM STAFF;
(2) MEMBERS OF THE BOARD; AND
(3) ANY CONSULTANTS THAT THE SECRETARY DETERMINES WILL
PROVIDE BROAD EXPERIENCE IN PAIN MANAGEMENT, SUBSTANCE ABUSE, AND
PRESCRIPTION DRUG DIVERSION HELP ACHIEVE THE DIVERSITY AND BALANCE OF
PERSPECTIVES REPRESENTED ON THE BOARD.
(C) (D) IN ACCORDANCE WITH REGULATION, THE MULTIDISCIPLINARY
CONSULTATION TEAM SHALL ASSIST A FEDERAL LAW ENFORCEMENT AGENCY, A
STATE OR LOCAL LAW ENFORCEMENT AGENCY, OR A LICENSING ENTITY THAT HAS
RECEIVED PRESCRIPTION MONITORING DATA FROM THE PROGRAM IN
INTERPRETING THE DATA AND CONSIDERING WHETHER THE DATA, IN THE CONTEXT
OF THE NATURE OF A PRESCRIBER'S OR A DISPENSER'S PRACTICE, A PATIENT'S
MEDICAL CONDITION, OR ANY OTHER RELEVANT FACTS, SUGGEST THE NEED FOR
FURTHER INVESTIGATION.
21-2A-05.
(A) FOR EACH MONITORED PRESCRIPTION DRUG THAT IS DISPENSED, A
DISPENSER SHALL SUBMIT TO THE PROGRAM INFORMATION SPECIFIED BY THE
SECRETARY, INCLUDING:
(1) A PATIENT IDENTIFIER;
(2) THE PRESCRIPTION DRUG DISPENSED;
- 3827 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
